We entered March with great energy and excitement for the upcoming activities that have forever defined this season: spring training baseball, national sales meetings, new product launch meetings, and of course full-contact action from medical congress meetings like AACR and ASCO. Enter COVID-19 and as we quickly shifted to a virtually Read more…
November is more than just the Season of Giving—it’s also Lung Cancer Awareness Month. Last week, my wife and I attended LUNGevity’s 7th annual Celebration of Hope Gala in NYC where I had the privilege of meeting many of the people in this picture. It’s truly inspiring to say that Read more…
The individual and family receiving a diagnosis and being confronted with the term “rare” can also hear “easily forgotten” and “not a priority” in terms of research and advocacy.
Patients want brands that prove that you “get them.” In terms of the HCP, telling physicians that your product is different is no longer sufficient to gain acceptance. Marketers must demonstrate and prove that their brand is different in order to stand out, build confidence, and ultimately change treatment decisions that shift business.